These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31591470)

  • 21. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat.
    Grealish S; Xie L; Kelly M; Dowd E
    Brain Res Bull; 2008 Nov; 77(5):312-9. PubMed ID: 18817852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
    Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease.
    Dutta D; Kundu M; Mondal S; Roy A; Ruehl S; Hall DA; Pahan K
    Neurobiol Dis; 2019 Dec; 132():104575. PubMed ID: 31445159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.
    Ikeda-Matsuo Y; Miyata H; Mizoguchi T; Ohama E; Naito Y; Uematsu S; Akira S; Sasaki Y; Tanabe M
    Neurobiol Dis; 2019 Apr; 124():81-92. PubMed ID: 30423474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model.
    Chiu CC; Lu CS; Weng YH; Chen YL; Huang YZ; Chen RS; Cheng YC; Huang YC; Liu YC; Lai SC; Lin KJ; Lin YW; Chen YJ; Chen CL; Yeh TH; Wang HL
    Mol Neurobiol; 2019 Jun; 56(6):3835-3853. PubMed ID: 30088174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases.
    Kim TW; Moon Y; Kim K; Lee JE; Koh HC; Rhyu IJ; Kim H; Sun W
    PLoS One; 2011; 6(10):e25346. PubMed ID: 22043283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of a Tissue Clearing Method for the Analysis of Dopaminergic Axonal Projections.
    Yamauchi K; Takahashi M; Hioki H
    Methods Mol Biol; 2021; 2322():141-150. PubMed ID: 34043200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.
    Bossers K; Meerhoff G; Balesar R; van Dongen JW; Kruse CG; Swaab DF; Verhaagen J
    Brain Pathol; 2009 Jan; 19(1):91-107. PubMed ID: 18462474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental modeling of preclinical and clinical stages of Parkinson's disease.
    Khaindrava VG; Kozina EA; Kudrin VS; Kucheryanu VG; Klodt PD; Narkevich VB; Bocharov EV; Nanaev AK; Kryzhanovsky GN; Raevskii KS; Ugrumov MV
    Bull Exp Biol Med; 2011 Mar; 150(5):566-9. PubMed ID: 22235385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AAV-Mediated Expression of Dominant-Negative ULK1 Increases Neuronal Survival and Enhances Motor Performance in the MPTP Mouse Model of Parkinson's Disease.
    Balke D; Tatenhorst L; Dambeck V; Ribas VT; Vahsen BF; Michel U; Bähr M; Lingor P
    Mol Neurobiol; 2020 Feb; 57(2):685-697. PubMed ID: 31446549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copper Increases Brain Oxidative Stress and Enhances the Ability of 6-Hydroxydopamine to Cause Dopaminergic Degeneration in a Rat Model of Parkinson's Disease.
    Cruces-Sande A; Rodríguez-Pérez AI; Herbello-Hermelo P; Bermejo-Barrera P; Méndez-Álvarez E; Labandeira-García JL; Soto-Otero R
    Mol Neurobiol; 2019 Apr; 56(4):2845-2854. PubMed ID: 30066305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal vulnerability in Parkinson's disease.
    Double KL
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S52-4. PubMed ID: 22166454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.